Acton, MA, United States of America

Joon Bok Lee

USPTO Granted Patents = 37 

 

 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Lowell, MA (US) (2023)
  • Acton, MA (US) (2022 - 2024)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
37 patents (USPTO):Explore Patents

Title: Joon Bok Lee - Shaping the Future of Diabetes Treatment through Innovation

Introduction:

Joon Bok Lee, a passionate inventor based in Acton, MA, is making waves in the field of healthcare technology with his groundbreaking innovations and relentless pursuit of excellence. With a total of 17 patents to his name, Lee's work is revolutionizing the way diabetes treatment is personalized and delivered.

Latest Patents:

Lee's latest patents focus on providing adaptivity and personalization in diabetes treatment. His inventions include techniques and devices that update insulin-to-carbohydrate ratios and total daily insulin doses, enabling more precise and tailored treatment for individuals with diabetes.

Career Highlights:

Currently working at Insulet Corporation, Lee has established himself as a key player in the development of innovative medical devices. His commitment to enhancing the quality of life for patients with diabetes is evident in his portfolio of patents and contributions to the healthcare industry.

Collaborations:

Among Lee's esteemed coworkers are Yibin Zheng and Jason B. O'Connor. Together, they form a dynamic team at Insulet Corporation, driving forward advancements in technology that have a direct impact on patient care and well-being.

Conclusion:

Joon Bok Lee's dedication to innovation and his significant contributions to the field of healthcare technology serve as inspiration for the next generation of inventors. By combining his expertise with a steadfast commitment to excellence, Lee is shaping the future of diabetes treatment and paving the way for a healthier, more personalized approach to medical care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…